Vats of ink have already been spilled on the implications of Brexit, and much more will come. As the U.K. unwinds its membership in the European Union, no doubt leading to other cascading moves that we can’t even anticipate today, uncertainty rules the day. But one thing we can be rather sure of is that the rejection of the free movement of labor will damage the pharmaceutical industry.
Topics: Pharma, Brexit, Kurt Kessler, PM360
Vats of ink have already been spilled on the implications of Brexit, and much more will come. As the U.K. unwinds its membership in the European Union, no doubt leading to other cascading moves that we can’t even anticipate today, uncertainty rules the day. But one thing we can be rather sure of is that the rejection of the free movement of labor will damage the pharmaceutical industry.
View All ZS Offices
